Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Fumiyuki Sato"'
Publikováno v:
Botanica Marina. 63:521-525
Grazing pressure by animals can change the distribution and biomass of seagrass. We examined grazing pressure by conducting transect surveys and acquiring aerial images by drone before and after the arrival of migratory birds along the Asadokoro tide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cec648ba3d0705c7d7b297f3c5700034
https://doi.org/10.1515/bot-2020-0045
https://doi.org/10.1515/bot-2020-0045
Autor:
Seiji Tsunematsu, Yoko Tsukuda, Naoya Sakamoto, Izumi Tsunematsu, Katsumi Terashita, Takuya Sho, Megumi Kimura, Fumiyuki Sato, Machiko Umemura, Ken Furuya, Atsushi Nagasaka, Takaaki Izumi, Takashi Meguro, Koji Ogawa, Junichi Yoshida, Kenichi Morikawa, Mineo Kudo, Tomoe Kobayashi, Masato Nakai, Kenichi Kumagai, Mitsuteru Natsuizaka, Yoshiya Yamamoto, Jun Ito, Goki Suda
Publikováno v:
Hepatology Research. 47:1127-1136
Background and Aim Hepatitis C virus infection is a risk factor for end-stage renal disease, renal graft failure, and hemodialysis patient mortality. However, the efficacy of direct-acting antiviral therapy for hepatitis C virus-infected patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0c3669af7dbd64a3560cec5c08e0422
https://doi.org/10.1111/hepr.12851
https://doi.org/10.1111/hepr.12851
Autor:
Megumi Kimura, Jun Ito, Koji Ogawa, Fumiyuki Sato, Yoko Tsukuda, Tomoe Shimazaki, Osamu Maehara, Kenichi Morikawa, Shunsuke Ohnishi, Katsumi Terashita, Masato Nakai, Takuya Sho, Makoto Chuma, Seiji Tsunematsu, Mitsuteru Natsuizaka, Goki Suda, Naoya Sakamoto
Publikováno v:
Journal of Medical Virology. 89:857-866
Hepatitis C virus (HCV) has been reported to hijack fatty acid metabolism in infected hepatocytes, taking advantage of lipid droplets for virus assembly. In this study, we analyzed the anti-HCV activity of l-carnitine, a substance involved in the tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0090349bb9449b17cca7241eb073352
https://doi.org/10.1002/jmv.24692
https://doi.org/10.1002/jmv.24692
Autor:
Kenichi Morikawa, Takuya Sho, Jun Ito, Izumi Takaaki, Goki Suda, Akinobu Taketomi, Koji Ogawa, Toshiya Kamiyama, Seiji Tsunematsu, Machiko Umemura, Naoya Sakamoto, Fumiyuki Sato, Megumi Kimura, Masato Nakai, Kazushi Yamasaki
Publikováno v:
Hepatology Research. 47:533-541
Aim Hepatic arterial infusion chemotherapy (HAIC) is a potent therapeutic option for advanced hepatocellular carcinoma (HCC). However, there are few known predictive factors of treatment response to HAIC. We clarified the most accurate predictive fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c69bf6422eeff5e7720f2d3dfd4c0dd
https://doi.org/10.1111/hepr.12775
https://doi.org/10.1111/hepr.12775
Autor:
Takaaki Izumi, Jun Ito, Seiji Tsunematsu, Fumiyuki Sato, Koji Ogawa, Megumi Kimura, Goki Suda, Naoya Sakamoto, Masato Nakai, Machiko Umemura, Kazushi Yamasaki, Takuya Sho, Yasuhito Tanaka, Koichi Watashi, Takaji Wakita, Kenichi Morikawa
Publikováno v:
Journal of Medical Virology. 89:267-275
Hepatitis B Virus (HBV) causes liver cirrhosis and hepatocellular carcinoma. Standard therapy includes treatment with interferon (IFN); however, its efficacy is limited. HBV has been reported to impair IFN signaling; however, the mechanism is unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a269ff0f6fe1b944bfd9fd58fd21c4db
https://doi.org/10.1002/jmv.24643
https://doi.org/10.1002/jmv.24643
Autor:
Mitsuteru Natsuizaka, Miki Tateyama, Hiromasa Horimoto, Keisuke Shinada, Seiji Tsunematsu, Goki Suda, Atsushi Nagasaka, Mineo Kudo, Machiko Umemura, Takaaki Izumi, Katsumi Terashita, Koji Ogawa, Takuya Sho, Ken Furuya, Yoko Tsukuda, Fumiyuki Sato, Masato Nakai, Naoya Sakamoto, Jun Konno, Megumi Kimura, Yoshiya Yamamoto, Kazushi Yamasaki, Tomoe Kobayashi, Kenichi Morikawa
Publikováno v:
Journal of gastroenterology. 51(7):733-740
Background: HCV infection in chronic hemodialysis patients is high, has a poor prognosis and high risk of renal graft failure, and requires nosocomial infection control measures. However, options of anti-HCV therapy in such patients are limited and u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b828957d120902e5307a1b3217034f8d
http://hdl.handle.net/2115/66412
http://hdl.handle.net/2115/66412
Autor:
Jun Ito, Kenichi Morikawa, Takuya Sho, Seiji Tsunematsu, Goki Suda, Katsumi Terashita, Megumi Kimura, Fumiyuki Sato, Takuto Miyagishima, Masato Nakai, Ken Furuya, Kenichi Kumagai, Kazushi Yamasaki, Takaaki Izumi, Mitsuteru Natsuizaka, Atsushi Nagasaka, Naoya Sakamoto, Yoko Tsukuda, Machiko Umemura, Koji Ogawa, Yoshiya Yamamoto, Tomoe Kobayashi, Hideaki Kikuchi
Publikováno v:
Hepatology Research. 46:1294-1303
Aim Sofosbuvir (SOF), a nucleotide analog pro-drug, targets hepatitis C virus (HCV) NS5B polymerase and shows potential for treating HCV infection, given its high efficacy and good barrier to resistance. However, in addition to the rare resistant-ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7a130c1d96629ea4d3ccc65cd1c7677
https://doi.org/10.1111/hepr.12685
https://doi.org/10.1111/hepr.12685
Autor:
Goki, Suda, Yoshiya, Yamamoto, Astushi, Nagasaka, Ken, Furuya, Mineo, Kudo, Yoshimichi, Chuganji, Yoko, Tsukuda, Seiji, Tsunematsu, Fumiyuki, Sato, Katsumi, Terasita, Masato, Nakai, Hiromasa, Horimoto, Takuya, Sho, Mitsuteru, Natsuizaka, Kouji, Ogawa, Shunsuke, Ohnishi, Makoto, Chuma, Yasuyuki, Fujita, Riichiro, Abe, Miki, Taniguchi, Mina, Nakagawa, Yasuhiro, Asahina, Naoya, Sakamoto
Publikováno v:
Hepatology research. 45(8):837-845
Aim: Telaprevir-based therapy for chronic hepatitis C patients is effective; however, the high prevalence of dermatological reactions is an outstanding issue. The mechanism and characteristics of such adverse reactions are unclear; moreover, predicti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::feda8c75e6c00188503a46569ff3d61c
http://hdl.handle.net/2115/62582
http://hdl.handle.net/2115/62582
Autor:
Hiroshi Nakagawa, Fumiyuki Sato, Kelly A. Whelan, Shinya Ohashi, Yoshimasa Kubota, Yuichi Shimizu, Katsumi Terashita, Osamu Maehara, Yutaka Hatanaka, Goki Suda, Hideaki Kinugasa, Mitsuteru Natsuizaka, Naoya Sakamoto, Yoshito Komatsu, Shingo Kagawa, Katsuji Marukawa, Shunsuke Ohnishi
Publikováno v:
Cancer Biology & Therapy. 16:933-940
There exists a highly tumorigenic subset of esophageal squamous cell carcinoma (ESCC) cells defined by high expression of CD44. A novel therapy targeting these cancer stem-like cells (CSCs) is needed to improve prognosis of ESCC. CSCs of ESCC have a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ab24dc51458a0566f1c77b7033c00d
https://doi.org/10.1080/15384047.2015.1040959
https://doi.org/10.1080/15384047.2015.1040959
Autor:
Hideaki Kinugasa, Koji Ogawa, Ayaka Asano, Kelly A. Whelan, Naoya Sakamoto, Koji Nakagawa, Mitsuteru Natsuizaka, Fumiyuki Sato, Hiroshi Takeda, Seiji Naganuma, Tomoe Shimazaki, Masato Nakai, Shunsuke Ohnishi, Goki Suda, Shinya Ohashi, Megumi Kimura, Takuya Sho, Osamu Maehara, Hiroshi Nakagawa, Yoshiyuki Fujimoto, Shingo Kagawa, Yoshito Komatsu, Kenichi Morikawa
In esophageal squamous cell carcinoma (ESCC), a subset of cells defined by high expression of CD44 and low expression of CD24 has been reported to possess characteristics of cancer stem-like cells (CSCs). Novel therapies directly targeting CSCs have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1737fa77ec65a78371d7ab3b093f46
https://europepmc.org/articles/PMC5862278/
https://europepmc.org/articles/PMC5862278/
